The Press: Navel-Gazing in Wasteland

The story was buried about as deep in the New York Times as a story can get. Bristol-Myers Co., reported Times Columnist Peter Bart on page 66 one morning last week, had switched its $11 million Bufferin account from one ad agency to another. The Bufferin switch was also immured, on the same day and in nearly identical construction, by Columnist Joseph Kaselow of the New York Herald Tribune. Eventually, the Bristol-Myers item made two afternoon Manhattan papers and flashed crosscountry to be interred in those posterior reaches of the daily press where the average reader seldom if ever ventures.

There, amid...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!